Evans syndrome epidemiology and demographics

Evans syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Evans syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Evans syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Evans syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Evans syndrome epidemiology and demographics
CDC on Evans syndrome epidemiology and demographics
Evans syndrome epidemiology and demographics in the news
Blogs on Evans syndrome epidemiology and demographics
Directions to Hospitals Treating Evans syndrome
Risk calculators and risk factors for Evans syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

• Considered a rare to very rare autoimmune disorder it has had few studies with cohorts often less than 30.
• The incidence of Evan’s Syndrome is not precisely known. The syndrome is reported to be a complication affecting 4-10% of those individuals with a particular type of thrombocytopenia known as idiopathic thrombocytopenic purpura.

Age

• The syndrome is more prevalent in children than in adults.

Gender

• Male and female are affected equally by Evans syndrome.